Motivational Interviewing With Diabetes Patients

Sponsor
Istanbul University-Cerrahpasa (Other)
Overall Status
Completed
CT.gov ID
NCT05187806
Collaborator
(none)
60
1
2
10
6

Study Details

Study Description

Brief Summary

This study was conducted in a quasi-experimental research design with a pretest-posttest control group to determine the effect of motivational interviewing on self-management and HbA1c in patients with type 2 diabetes. The sample of the study consisted of 25 experimental and 26 controls, who applied to an outpatient clinic in a training and research hospital.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: motivational interview
N/A

Detailed Description

This study was conducted in a quasi-experimental research design with a pretest-posttest control group to determine the effect of motivational interviewing on self-management and HbA1c in patients with type 2 diabetes. The sample of the study consisted of 25 experimental and 26 controls, who applied to an outpatient clinic in a training and research hospital. After the pretest, the experimental group was intervened with a motivational interview (MI) method that consisted of four sessions; the control group received routine treatment.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Masking Description:
Without knowing that participants are in the experimental or control group
Primary Purpose:
Supportive Care
Official Title:
Effects of Motivational Interviewing Intervention on Self- Management and HbA1c in Type 2 Diabetes Patients
Actual Study Start Date :
Feb 7, 2017
Actual Primary Completion Date :
May 7, 2017
Actual Study Completion Date :
Dec 7, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental group

After the pretest, the experimental group was intervened with a motivational interview (MI) method that consisted of four sessions of 30-60 (mean 45 min) min each. The sessions were structured according to the Behavior Change Stage Identification Form developed by the researcher by making use of the trans-theoretical model and adapting it to diabetic patients. The subject of the first session was "Opening, Structuring the Discussion, and Establishing the Agenda"; the subject of the second session was "Improving Motivation for Change"; the subject of the third session was "Summarizing, Support, and Talking about the Change"; and the subject of the fourth session was "Evaluation" . The discussions were completed in four weeks, with one discussion held every week. The final test and the Diabetes Self-Management Instrument were applied again to the members of the intervention group in the third month after completion of the MI method sessions.

Behavioral: motivational interview
After the pretest, the experimental group was intervened with a motivational interview (MI) method that consisted of four sessions.The pretest and posttest Diabetes Self-Management Scale total scores and HbA1c values of the patients in the experimental and control groups were compared.

No Intervention: Control group

The control group received routine treatment. The final test and the Diabetes Self-Management Instrument were applied again to the members of the control group in the third month.

Outcome Measures

Primary Outcome Measures

  1. Comparison of the pretest-posttest Diabetes Self-management Instrument-35 scores [3 months]

    The instrument is comprised of 35 questions covering the period from the previous three months to determine the frequency of the implementation of the self-management skills of the patients. The total score for the Instrument ranged from 35 to 140. A higher score showed that self-management activities were implemented on a more regular basis. Interventions consisted of four sessions of 30-60 (mean 45 min) min each. The sessions were structured according to the Behavior Change Stage Identification Form developed by the researcher by making use of the trans-theoretical model and adapting it to diabetic patients.The discussions were completed in four weeks, with one discussion held every week. The final test and the Diabetes Self-Management Instrument were applied again to the members of the intervention group in the third month after completion of the MI method sessions and in the third month to the control group.

Secondary Outcome Measures

  1. Comparison of the pretest-posttest HbA1c values [3 months]

    The pretest and posttest HbA1c values of the patients in the experimental and control groups were compared in the third month.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years and older

  • Having been diagnosed with type 2 diabetes for more than 3 months

  • Being in the contemplation

  • Preparation, and/or action stages of any section of the Behavioral Change Stage Identification Form of the Trans-Theoretical Model

  • Having HbA1c levels above 6

  • Agreeing to take part in the study

Exclusion Criteria:
  • Having a perception disorder that will prevent communication

  • Having been diagnosed with any mental disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ministry of Health, Gaziosmanpasa Training and Research Hospital Istanbul Turkey 34255

Sponsors and Collaborators

  • Istanbul University-Cerrahpasa

Investigators

  • Principal Investigator: Deniz Kaya Meral, Phd, Ministry of Health, Gaziosmanpasa Training and Research Hospital

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Deniz KAYA MERAL, Principal Investigator, Istanbul University-Cerrahpasa
ClinicalTrials.gov Identifier:
NCT05187806
Other Study ID Numbers:
  • NursePsychiatric
First Posted:
Jan 12, 2022
Last Update Posted:
Jan 12, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Deniz KAYA MERAL, Principal Investigator, Istanbul University-Cerrahpasa
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 12, 2022